Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and Therapy

Guanqiong Na1,2, Canxia He3, Shunxi Zhang1

  • 1Department of Nutrition, School of Public Health and Management, Wenzhou Medical University, Wenzhou 325035, China.

Insights

Dietary isothiocyanates show potent anti-cancer activity through novel mechanisms. However, their hormetic effects mean benefits depend on dose, warranting caution and use as adjunctive treatments.

Area of Science:

  • Nutritional Science
  • Cancer Research
  • Pharmacology

Background:

  • Diet significantly impacts health, with phytochemicals like isothiocyanates offering protective benefits.
  • Isothiocyanates are recognized for their potential to reduce cancer risk.
  • Emerging research reveals novel mechanisms of isothiocyanate action against cancer.

Purpose of the Study:

  • To review the anti-cancer activities and novel mechanisms of isothiocyanates.
  • To discuss the complexities of isothiocyanate hormesis and dose-dependent effects.
  • To explore the potential of isothiocyanates as adjunctive cancer therapies and delivery systems.

Main Methods:

  • Review of in vitro and in vivo studies on isothiocyanate anti-cancer effects.
  • Analysis of recent research on isothiocyanate mechanisms of action.
  • Discussion of hormesis, dose-dependency, and formulation strategies.

Main Results:

  • Isothiocyanates exhibit potent anti-cancer activities via multiple pathways.
  • Mechanisms include modulation of tumor microenvironment, stem cell self-renewal, energy metabolism, and microbiota.
  • Hormetic/biphasic effects necessitate careful consideration of dose and endpoint.
  • Protection against Helicobacter pylori infection is also noted.

Conclusions:

  • Isothiocyanates are promising cancer-preventative phytochemicals with diverse mechanisms.
  • Their hormetic nature requires awareness of potential adverse effects and dose optimization.
  • Dietary isothiocyanates may be best utilized as adjunctive treatments alongside conventional therapies.
  • Novel delivery systems like nano-formulations show potential for enhanced efficacy.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
472
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
615
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K